ICT:RPT:0815:Xenex Disinfection Report


Underwritten for a limited time courtesy of Xenex

Making the Business Case for Technology at the Intersection of Cost and Quality

Report Summary

Infection preventionists, environmental services directors, purchasing managers and members of the hospital C-suite are finding themselves at the intersection of cost and quality when it comes to evaluating technology for the prevention of healthcare-associated infections (HAIs). In this report, we take a look at the fiscal trends affecting hospital reimbursement, the necessity of achieving return on investment (ROI), and the importance of making an effective business case for infection control-related services and technologies.

Editor's Take

Making the business case for infection prevention-related products and services to help avoid hospital-acquired conditions and infections -- and hospital readmissions -- is an imperative within the value-based purchasing framework. This report helps infection preventionists and members of the hospital C-suite understand how to find ROI in a technology-related capital purchase.

Takeaways for Your Business

  • Review healthcare reform's impact on purchasing and reimbursement
  • Explore the steps of making an effective business case
  • Discover how automated area decontamination technology can assist in infection prevention